Today, we revisit the Biomet Deferred Prosecution Agreement. As you may recall, one of the major failings of the company, which led to the violations of the Foreign Corrupt Practices Act were those of the company’s Internal Audit Department. I asked my colleague Henry Mixon, CPA and FCPA internal controls specialist, for his reaction to the recent posting regarding lessons for Internal Audit in the recent Biomet matter.